Campbell Murray - Profile and Investment Details

Investor Profile

Campbell Murray is a Venture Capital, Advisor, Private Equity Firm, Angel/Individual, Investment Partner based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as GEMMA Biotherapeutics, Euthymics Bioscience, Inc., Umoja Biopharma, Lumos Pharma, Cerevance, ImaginAb, Synchron, Neurovance, Inc.BioNano Genomics, Inc., ImmunOs Therapeutics AG, Novartis, Akouos, Carbon Biosciences, Lemonaid Health, TScan Therapeutics, . Over time, Campbell Murray has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Campbell Murray is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Regenerative Medicine, Wellness, Healthcare Innovation, Life Science, Medical Technologies, Finance, Biotechnology, Medical Devices, Precision Medicine, Clinical Trials, Personalized Medicine, Digital Health, Information Technology, B2B, Therapeutics, Health Tech may find it worthwhile to explore potential connections with Campbell Murray, as their portfolio suggests a familiarity and interest in this area.

Understanding Campbell Murray’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.